This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CVS Caremark Prepared To Help Customers Access Care With New Affordable Care Act Coverage

WOONSOCKET, R.I., Dec. 31, 2013 /PRNewswire-FirstCall/ -- As coverage under the Affordable Care Act (ACA) gets underway on January 1 for millions of Americans, CVS Caremark (NYSE: CVS) is ready to help patients who may experience coverage issues or have questions as they access care and prescription medications under new plans for the first time.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

"CVS/pharmacy is committed to assisting our patients who may encounter disruptions in their prescription insurance coverage beginning January 1," said Helena B. Foulkes, President, CVS/pharmacy and Executive Vice President, CVS Caremark. "Our pharmacy teams will provide information to help patients contact the appropriate health plan or insurance exchange, and we are actively communicating with insurance plans and government agencies to help minimize disruption to care whenever possible."

In some circumstances and based on clinical considerations, CVS/pharmacy will assist patients who are experiencing a temporary disruption in insurance coverage with a transitional or "bridge" supply of medication to support their continuity of care. A bridge supply is a prescription of 15 or 30 days. For patients who express financial hardship, a bridge supply may be provided as a courtesy to help them remain adherent to their medication therapy while they resolve their coverage issues.

MinuteClinic, the medical clinic inside select CVS/pharmacy stores, will be providing similar flexibility for patients who may be in transition with their health care coverage.

"We want to play our part in the medical community to support our patients' health care needs during this time because some plan details are still being determined," said Andrew Sussman, M.D., President, MinuteClinic and Senior Vice President/Associate Chief Medical Officer, CVS Caremark.

"As a health care provider, CVS Caremark is dedicated to helping people on their path to better health," added Foulkes.  "As the ACA and other health insurance coverage changes roll out beginning January 1, we will do all we can to provide guidance and support for patients during this complex time."

About CVS CaremarkCVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,600 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 750 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans.  As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications.  Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

SOURCE CVS Caremark

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs